ROCKVILLE, Md., May 10, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial Capital Markets Seventh Annual Equity Conference held May 16-17, 2011 at the Hard Rock Hotel & Casino in Hollywood, Florida. Dr. Fahim's presentation is scheduled for Tuesday, May 17, 2011, at 11:00 a.m., EDT.
You can access the web cast of this presentation on the company's "Events and Webcasts" page at www.nabi.com or at:
file:///C:/Documents%20and%20Settings/stomlinson/Desktop/Updates%20Weblinks%205-5-11.xls#RANGE!B2#RANGE!B2">http://noble.mediasite.com/mediasite/Viewer/?peid=b0139435c6cb4287867af7ffb3f7adf11d
Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your browser. Remove the space if one exists.
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX® (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company is headquartered in Rockville, Maryland. For additional information about Nabi Biopharmaceuticals, please visit www.nabi.com